why does glp 1 make you cold do GLP-1s do this? 🥶🔥 If started a GLP-1 and suddenly feel for no reason… you're not imagining it. Welcome to the chills. ❄️ Some say it's from Understanding Why You Feel Cold

Not a nurse practitioner reading from a script

Approval Timeline and Availability CagriSema: Ahead in the Race FDA Submission: December 18, 2025 (NDA filed) Expected FDA Decision: Q4 2026 or Q1 2027 Predicted Launch: Mid-2027 Advantage: 6-12 month head start on retatrutide REDEFINE Program Status: REDEFINE-1: Completed (obesity, 20.4% weight loss) REDEFINE-2: Completed (type 2 diabetes, 13.7% weight loss) REDEFINE-3: Ongoing (cardiovascular outcomes trial) REDEFINE-8: Ongoing (body composition study) High-dose CagriSema (2.4/7.2mg): Starting late 2026 Retatrutide: More Trials Needed FDA Submission: Expected Q4 2026 or Q1 2027 Expected FDA Decision: Late 2027 Predicted Launch: Q1-Q2 2028 TRIUMPH Program Status: TRIUMPH-4: Completed (osteoarthritis, 28.7% weight loss) TRIUMPH-1: Complete 28.3% weight loss (May 2026) TRIUMPH-2: Expected Q3Q4 2026 (obesity + type 2 diabetes) TRIUMPH-3: Expected later 2026 (obesity + cardiovascular disease) TRIUMPH-6: Weight maintenance trial (ongoing) Disadvantage: Needs more trials before submission, 6-12 month delay vs CagriSema

3.3 Ferroptosis in IE related diseases In addition to -thal, IE also happens to be present in various hematological disorders, including congenital dyserythropoietic anemia, hereditary sideroblastic anemia, and anemia in acquired conditions such myelodysplastic syndrome (MDS) ( X-linked sideroblastic anemia is a disease in which mutations in the erythroid-specific 5-aminolevulinate synthase (ALAS2) gene cause excess iron accumulation and, IE

Given the multiple pathophysiologic targets that exist in the setting of T2DM, it is common to encounter patients who require the use of multiple antihyperglycemic agents to successfully reach treatment goals

Here are several ways in which lip types are different